Ultragenyx Pharmaceutical(DE:UP0)
€14.58-0.36 (-2.38%)
DE:UP0
Ultragenyx Pharmaceutical earnings date
€14.58
At close:-0.36 (-2.38%)
Ultragenyx Pharmaceutical (UP0) Q2 2022 Earnings Report
2 Followers
DE:UP0 Q2 2022 EPS Results
- Actual EPS
- -EUR 2.04
- Consensus EPS
- -EUR 1.58
- Beat/Miss
- Missed by -EUR 0.46
- One Year Ago EPS
- -EUR 1.64
DE:UP0 Q2 2022 Revenue Results
- Actual Revenue
- EUR 80.76M
- Expected Revenue
- EUR 79.35M
- Beat/Miss
- Beat by +EUR 1.41M
- YoY Revenue Growth
- +2.72%
Earnings Announcement Details
- Quarter
- Q2 2022
- Date
- 07/28/2022
- Time
- After Close
- Conference Call
- Thursday, July 28, 2022
DE:UP0 Upcoming Earnings
Ultragenyx Pharmaceutical's next earnings date is estimated for February 18, 2027, based on past reporting schedules.
Q2 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:UP0 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 18, 2027 | 2026 (Q4) | 2.16- | -1.17 | ― | ― |
| Nov 03, 2026 | 2026 (Q3) | -0.99-1.05 | -1.64 | 35.91% (+0.59) | |
| Aug 04, 2026 | 2026 (Q2) | -1.12-0.81 | -1.06 | 23.08% (+0.24) | |
| May 05, 2026 | 2026 (Q1) | -1.35-1.66 | -1.42 | -17.20% (-0.24) | |
| Feb 12, 2026 | 2025 (Q4) | -0.99-1.17 | -1.26 | 7.19% (+0.09) | |
| Nov 04, 2025 | 2025 (Q3) | -1.12-1.64 | -1.27 | -29.29% (-0.37) | |
| Aug 05, 2025 | 2025 (Q2) | -1.17-1.06 | -1.37 | 23.03% (+0.32) | |
| May 06, 2025 | 2025 (Q1) | -1.44-1.42 | -1.83 | 22.66% (+0.42) | |
| Feb 13, 2025 | 2024 (Q4) | -1.18-1.26 | -1.37 | 8.55% (+0.12) | |
| Nov 05, 2024 | 2024 (Q3) | -1.34-1.27 | -2.02 | 37.22% (+0.75) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
